Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 20, 2026
Artisan Small Cap Fund posted weak absolute and relative performance in Q3 2026, with the Investor Class (ARTSX) returning -9.75% net of fees, underperforming the Russell 2000 Growth Index benchmark return of -9.39%. Year to date, the strategy has generated a net return of 10.65%, trailing the benchmark's 10.71% net gain. The broader market environment witnessed small caps underperforming large caps by 880 basis points—one of the widest quarterly deficits in index history—driven by rising bond yields, a more hawkish central bank posture following the Federal Reserve's 25-basis-point interest rate increase, and sharp factor rotations away from higher-beta, long-duration growth assets. The investment team noted heightened macroeconomic crosscurrents, characterized by the 30-year Treasury yield reaching multi-decade highs, elevated oil prices surpassing $100 per barrel, and mounting scrutiny surrounding the capital intensity and return timeline of artificial intelligence infrastructure investments. Within the portfolio's defined power alleys, health care served as the sole positive contributor (+6.4% absolute return; ~250 bps relative contribution), while industrials (-140 bps relative impact) and information technology detracted due to supply chain frictions and hardware delivery bottlenecks in data center ecosystems. Portfolio turnover remained active as the managers initiated 15 new Garden positions while harvesting 19 campaigns. Key actions included initiating positions in Glaukos, Manhattan Associates, and 10x Genomics, alongside scaling up exposure to Weatherford International and Vita Coco. Conversely, the fund completely exited positions in Ionis Pharmaceuticals following Phase 3 clinical trial setbacks, ServiceTitan due to decelerating transaction growth and management turnover, and Birkenstock amid rising consumer discounting and promotional activity.
The fund seeks to generate attractive risk-adjusted long-term capital appreciation by investing in franchise businesses undergoing identifiable, accelerating profit cycles that trade at understandable valuation multiples.
The investment team expects stronger earnings profiles and idiosyncratic profit cycles to insulate holdings against higher interest rates while creating attractive multiyear investment opportunities across small caps.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Artisan Partners Small Cap Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.